Universal Technical Institute (UTI) is back on investors’ radars after fiscal second quarter results showed higher sales than a year earlier, paired with much lower net income and earnings per share.
See our latest analysis for Universal Technical Institute.
The earnings update followed a powerful run, with the share price rising 59.26% year to date and delivering a very large 5 year total shareholder return, although the 1 day move fell 4.67%.
If UTI’s move has you thinking about where else momentum could build next, it may be worth checking a screener focused on 19 top founder-led companies
With the stock up 59.3% year to date, trading near a US$42.50 analyst target and showing much weaker recent earnings, investors now have to ask whether there is still value left here or if the market is already pricing in future growth.
At $39.56, Universal Technical Institute trades below the most followed narrative fair value of $42.50, putting the recent Q2 reset against a higher long term bar.
Strategic investments in campus expansion, new program rollouts (notably in HVAC, aviation, and allied health), and digitization efforts are expected to support top line expansion. At the same time, the consolidation of core systems should facilitate operating efficiencies and drive long term margin improvement beyond the near term investment cycle.
Curious what sits behind that higher fair value tag? The narrative leans heavily on faster top line growth, richer margins, and a future profit multiple that assumes real execution.
Result: Fair Value of $42.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that story can unravel quickly if new campuses fail to attract enough students, or if tougher regulation squeezes funding and pushes up compliance costs.
Find out about the key risks to this Universal Technical Institute narrative.
The narrative fair value argues UTI is 6.9% undervalued at $39.56, but the valuation based on earnings tells a different story. The stock trades on a P/E of 51x, compared with about 16.6x for the US Consumer Services industry and a fair ratio of 27.8x. This suggests investors are paying a high premium that could matter if expectations change.
See what the numbers say about this price — find out in our valuation breakdown.
With mixed signals on value and expectations, now is the time to look through the data yourself and decide how the balance of risks and rewards stacks up, then weigh that against the 1 key reward and 2 important warning signs
If UTI is already on your watchlist, do not stop there. Broaden your opportunity set now so you are not relying on one stock story alone.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com